Reduced numbers of circulating CD28-negative CD4+ cells in patients with rheumatoid arthritis chronically treated with abatacept-Reference-Cited by-同舟云学术

Reduced numbers of circulating CD28-negative CD4+ cells in patients with rheumatoid arthritis chronically treated with abatacept

Published:2013-04-04 Issue:4 Volume:16 Page:469-471
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Gómez-García Lorena¹,Ramírez-Assad Cecilia²,Vargas Angelica²,Massó Felipe³,Sánchez-Muñoz Fausto¹,Márquez-Velasco Ricardo¹,Amezcua-Guerra Luis M.¹,Bojalil Rafael¹⁴

Affiliation:

1. Department of Immunology; Instituto Nacional de Cardiología Ignacio Chávez; Mexico City Mexico

2. Department of Rheumatology; Instituto Nacional de Cardiología Ignacio Chávez; Mexico City Mexico

3. Department ofPhysiology; Instituto Nacional de Cardiología Ignacio Chávez; Mexico City Mexico

4. Department ofHealth Care; Universidad Autónoma Metropolitana Xochimilco; Mexico City Mexico

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.12056/fullpdf

Reference9 articles.

1. Rheumatoid arthritis: a role for immunosenescence?;Lindstrom;J Am Geriatr Soc,2010

2. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis;Martens;Arthritis Rheum,1997

3. CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients;Gerli;Circulation,2004

4. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression;Wells;J Rheumatol,2011

5. Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical response;Scarsi;J Rheumatol,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD28null T cells in aging and diseases: From biology to assessment and intervention;International Immunopharmacology;2024-04

2. Senescent CD4+CD28null cells are increased in chronic hyperuricemia, show aberrant effector phenotypes, and are reversed after allopurinol therapy: a proof-of-concept pilot study;Clinical Rheumatology;2023-04-18

3. Age-related mechanisms in the context of rheumatic disease;Nature Reviews Rheumatology;2022-11-03

4. Accumulation of CD28null Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients;Biomolecules;2021-09-29

5. T Cells in Autoimmunity-Associated Cardiovascular Diseases;Frontiers in Immunology;2020-10-07